> News > Company News

Company News

Amhwa sodium hyaluronate raw material has been approved by the -CEP certificate

Recently, Amhwa sodium hyaluronate API obtained the European Pharmacopeia applicability certification issued by the European Agency for Quality of Medicines EDQM, namely the EU CEP certificate.

The patent of "Low molecular weight hyaluronic acid or its salt and its preparation method" of Amhwa Biological was approved in Japan

Recently, Shandong Amhwa Biopharmaceutical Co., LTD. The "Low molecular hyaluronic acid or its salt and its preparation method" patent was officially approved by the Japanese Licensing Office and issued a certificate.

Amhwa Biology - the world's leading manufacturer of hyaluronic acid Amhwa Biology: to become a leading global manufacturer of hyaluronic acid

On June 25, 2023, the China Medical Aesthetics Frontier Industry Trend Conference -Hainan Station was held grandly. This conference gathered industry elite representatives such as Hainan industry associations, high-quality upstream brand parties, excellent doctors, and institutions to jointly voice ......

<1 2 >